ijms-logo

Journal Browser

Journal Browser

Wnt/β-Catenin Signaling in Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 20 April 2025 | Viewed by 963

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
Interests: cancer; gene expression

E-Mail Website
Guest Editor
Unit of Experimental Pathology, Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
Interests: molecular biology assessment methods for hereditary susceptibility, gene expression assays, and cellular and tissue phenotypic markers involved in tumor onset and progression.
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The Wnt signaling pathways are implicated in cell fate, migration, and polarity, as well as embryonic organogenesis, stem cell renewal, tissue homeostasis, and epithelial mesenchymal transition (EMT). Wnt signaling involves the canonical or Wnt/β-catenin dependent pathway and the non-canonical or β-catenin-independent pathway, which further comprises the Planar Cell Polarity and the Wnt/Ca2+ pathways. Aberrant activation of Wnt/β-catenin signaling is closely involved in the onset, development, and progression of numerous human malignant tumors and is predictive of poor prognosis. Therefore, deregulation of Wnt may represent an interesting therapeutic target in cancer treatment. So far, despite the efforts of researchers, the pleiotropic role of the Wnt/β-catenin pathway in critical cellular functions and the crosstalk with other signaling pathways have made the design of new targeted drugs difficult.

Understanding the role of Wnt/β-catenin signaling and its crosstalk pathways in cancer development can provide new insights into various pathogenetic mechanisms with the aim (1) to identify molecules of the Wnt signaling cascade that may represent potential prognostic and predictive markers of malignancy and (2) to develop new therapeutic approaches for defining molecular strategies useful in the pharmacological treatment of Wnt-related tumors.

In light of the above, in this Special Issue of the International Journal of Molecular Sciences on ‘Wnt/β-Catenin Signaling in Cancer’, we welcome original basic and translational research and review articles, which may help to elucidate the role played by Wnt signaling in tumor initiation, progression, and therapeutic response.

Dr. Teresa Catalano
Dr. Gitana Maria Aceto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Wnt/β-catenin pathway

  • tumors
  • gene expression
  • molecular targets
  • tumor microenvironment
  • carcinogenesis and metastasis
  • biomarkers
  • therapeutic approaches

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

32 pages, 1472 KiB  
Review
Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges
by Anna Gajos-Michniewicz and Malgorzata Czyz
Int. J. Mol. Sci. 2024, 25(23), 12804; https://doi.org/10.3390/ijms252312804 - 28 Nov 2024
Viewed by 659
Abstract
Targeted therapies and immunotherapies have improved the clinical outcome of cancer patients; however, the efficacy of treatment remains frequently limited due to low predictability of response and development of drug resistance. Therefore, novel therapeutic strategies for various cancer types are needed. Current research [...] Read more.
Targeted therapies and immunotherapies have improved the clinical outcome of cancer patients; however, the efficacy of treatment remains frequently limited due to low predictability of response and development of drug resistance. Therefore, novel therapeutic strategies for various cancer types are needed. Current research emphasizes the potential therapeutic value of targeting WNT/β-catenin dependent signaling that is deregulated in various cancer types. Targeting the WNT/β-catenin signaling pathway with diverse synthetic and natural agents is the subject of a number of preclinical studies and clinical trials for cancer patients. The usage of nature-derived agents is attributed to their health benefits, reduced toxicity and side effects compared to synthetic agents. The review summarizes preclinical studies and ongoing clinical trials that aim to target components of the WNT/β-catenin pathway across a diverse spectrum of cancer types, highlighting their potential to improve cancer treatment. Full article
(This article belongs to the Special Issue Wnt/β-Catenin Signaling in Cancer)
Show Figures

Figure 1

Back to TopTop